for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
agreement 312.0 1.9 0.6 0.0 (311.4) (99.8) Gain on disposals of investments in subsidiaries 314.8 1.9 458.6 3.2 143.7 45.7 Other income 262.0 1.6 465.3 3.3 203.3 77.6 Total Revenues 16,637.8 100.0 14,122.1
พฤศจิกายน 2559 ที่ประชมุคณะกรรมการบริษัทฯ ครัง้ที่ 9/2559 ได้มีมตอินมุตัิท าสญัญา “Business Administration Agreement” และจ่ายคา่ธรรมเนียมให้กบับริษัท อิออน ไฟแนนเชียล เซอร์วิส จ ากดั (“AFS”) เป็นจ านวน
ทําสญัญา “Business Administration Agreement” และจ่ายคา่ธรรมเนียมให้กบับริษัท อิออน ไฟแนนเชียล เซอร์วิส จํากดั (“AFS”) มลค่ารวมของรายการู : มลค่าู บริษัท เยน บาท AEONTS 255,955,000 78,273,599 ACSS 11,477,000
long-term loans which was due and this long-term loan agreement will be due in 2018. Liabilities under finance lease agreements, net of current portion decreased by 12.8 MB or representing decreased of
for sale of the investment units of a mutual fund or in an agreement for private fund management, as the case may be; (4) the evidentiary documentation supplementing the consideration for investing in
for sale of the investment units of a mutual fund or in an agreement for private fund management, as the case may be; (4) the evidentiary documentation supplementing the consideration for investing in
for sale of the investment units of a mutual fund or in an agreement for private fund management, as the case may be; (4) the evidentiary documentation supplementing the consideration for investing in